NEWSpublisher 2007 :: AngloChinese Investments
SEARCH NEWS
date from:
date to:
company:
search for string:
NEWS SECTIONS
COMPANY GROUPS
TOP NEWS
» 23/07/2009 [Company watch]
China Aoxing Pharmaceutical Corp. Receives Renewal of GMP Certification for Capsule Dosage Form of Pharmaceutical Products
» 15/03/2010 [Industry news]
Recordati S.p.A And Lee Pharmaceutical Announce Partnership For Zanidip(R) In China
» 26/10/2009 [Finance]
China Growth to Remain Fast in Fourth Quarter, Official Says
» 17/08/2009 [Industry news]
Chindex Posts Profit on Product Sales, Health Services
» 07/05/2010 [Industry news]
Hong Kong: Recall of all products manufactured by Quality Pharmaceutical Lab Ltd
COMPANY NEWS back to previous page show list
»04/12/2009 [Company watch]
Tianyin Pharma Calls for 75% Improvement in 2011

Tianyin Pharmaceutical, Co., Inc., (NYSE Alternext: TPI), a modernized TCM company, issued guidance calling for a 75% improvement in fiscal year 2011 (ending June 30, 2011) results. The company said it expects revenue of $113 million for fiscal 2011, up from $63.6 million in 2010, and net income of $19.6 million, a rise from $11.3 million in the current year.

 

Tianyin Pharmaceutical, Co., Inc., (NYSE Alternext: TPI), a modernized TCM company, issued guidance calling for a 75% improvement in fiscal year 2011 (ending June 30, 2011) results. The company said it expects revenue of $113 million for fiscal 2011, up from $63.6 million in 2010, and net income of $19.6 million, a rise from $11.3 million in the current year.

Investors were very pleased to hear the news. They sent the stock 99 cents higher to $4.72, a 26% jump. Volume was very heavy.

Tianyin Pharma said its new JV, which produces macrolide antibiotic API, would add $22.5 million in revenues and $1.4 million in net income in fiscal 2011. Tianyin’s partner in the enterprise is Sichuan Jiangchuan Pharmaceutical Co. The majority of the company’s sales ($90.8 in revenues and $18.2 in net income) are derived from branded specialty products.

The company plans to continue its business plan, which is to grow organically and make acquisitions. Tianyin Pharma has introduced ten new products in the last year.

 


AngloChinese Investments ltd.
Home | Company news | TOP 50 | Events | About us
C&F Bright Solutions ltd.